Your session is about to expire
← Back to Search
Text Reminders for COVID-19 Booster Uptake
N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after getting the text message
Awards & highlights
Study Summary
This trial tests if sending text reminders and messages can increase the uptake of COVID-19 booster vaccinations.
Who is the study for?
This trial is for adults who have completed their initial COVID-19 vaccine series, haven't had a booster in the last two months, and are registered with UCLA Health with an SMS-capable phone. It excludes those who've already scheduled or received a bivalent booster.Check my eligibility
What is being tested?
The study tests if text messages can increase uptake of the COVID-19 bivalent booster. Different message strategies include eligibility reminders, links to vaccination sites (narrow/broad options), and emphasizing doctors' recommendations and vaccine value.See study design
What are the potential side effects?
Since this trial focuses on communication methods rather than medical interventions, there are no direct side effects from participating. However, general side effects of COVID-19 vaccines may apply when individuals decide to get vaccinated.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week after getting the text message
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after getting the text message
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Secondary Immunization
Secondary Immunization
Secondary outcome measures
Link click rate in 1 week
booster take-up at UCLA/CVS in 2 weeks
booster take-up at UCLA/CVS in 4 weeks
Trial Design
6Treatment groups
Experimental Treatment
Active Control
Group I: Facilitate action narrowlyExperimental Treatment2 Interventions
Group II: Facilitate action broadlyExperimental Treatment2 Interventions
Group III: Boost intentions onlyExperimental Treatment2 Interventions
Group IV: Boost intentions and facilitate action narrowlyExperimental Treatment3 Interventions
Group V: Boost intentions and facilitate action broadlyExperimental Treatment3 Interventions
Group VI: HoldoutActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,537 Previous Clinical Trials
10,127,500 Total Patients Enrolled
21 Trials studying COVID-19
733,604 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are 18 years old or older.You have already received a specific booster shot before getting the text message.You have already received all the doses of a COVID-19 vaccine.Your last COVID-19 vaccine, including any booster shots, was given at least two months before the trial starts.
Research Study Groups:
This trial has the following groups:- Group 1: Facilitate action narrowly
- Group 2: Boost intentions and facilitate action broadly
- Group 3: Boost intentions and facilitate action narrowly
- Group 4: Holdout
- Group 5: Facilitate action broadly
- Group 6: Boost intentions only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
COVID-19 Patient Testimony for trial: Trial Name: NCT05586204 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical study actively enrolling participants at the present moment?
"Clinicaltrials.gov verifies that this clinical trial, first published on 18th October 2022, is actively enrolling participants. The study has been revised most recently on 8th November 2022."
Answered by AI
What is the scope of patient involvement in this clinical trial?
"Affirmative. According to clinicaltrials.gov, the investigation posted on October 18th 2022 is actively searching for participants with 140000 individuals required from 1 site."
Answered by AI
Who else is applying?
What state do they live in?
California
What site did they apply to?
UCLA Health Department of Medicine, Quality Office
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I have a low immune system and I’m trying to find a study that will prevent me from getting sick diagnosis.
PatientReceived no prior treatments
Share this study with friends
Copy Link
Messenger